製品番号: HY-19825

Rebeccamycin

Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin appears to exert its primary antineoplastic effect by poisoning topoisomerase I and has negligible effect on protein kinase C and topoisomerase II.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 93908-02-2
分子式: C₂₇H₂₁Cl₂N₃O₇
分子量:570.38

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (278 KB)

Rebeccamycin 構造式

CAS 番号: 93908-02-2

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

One-stop CDMO Service

One-Stop Platform：From Independent R&D to Pilot-Scale Production

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体外実験
- 体内実験
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target^[1]

Topoisomerase I

Traditional Cytotoxic Agents

Topoisomerase アイソフォーム固有の製品をすべて表示 :

ADC Payloads アイソフォーム固有の製品をすべて表示 :

Antibiotic アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	0.3 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity in vitro against A549 (human non-small lung carcinoma) cell line. Antiproliferative activity in vitro against A549 (human non-small lung carcinoma) cell line.	[PMID: 11882002]
B16	IC₅₀	0.48 μM Compound: 1	Inhibition of murine B16 Melanoma cell proliferation Inhibition of murine B16 Melanoma cell proliferation	[PMID: 9341921]
B16	IC₅₀	0.48 μM Compound: 1 (Rebeccamycin)	Antiproliferative activity measured against murine B16 melanoma cells Antiproliferative activity measured against murine B16 melanoma cells	[PMID: 9572888]
B16	IC₅₀	0.48 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity against B16 mouse melanoma cells Antiproliferative activity against B16 mouse melanoma cells	[PMID: 8893841]
CEM-SS	CC₅₀	1.05 μM Compound: 1	The cytotoxicity was evaluated in in HIV -I Lai infected CEM-SS cells. The cytotoxicity was evaluated in in HIV -I Lai infected CEM-SS cells.	[PMID: 10346933]
CEM-SS	CC₅₀	1.05 μM Compound: 1 (Rebeccamycin)	Cytotoxicity against HIV-1 Lai infected CEM-SS cells Cytotoxicity against HIV-1 Lai infected CEM-SS cells	[PMID: 10052965]
CEM-SS	CC₅₀	1.05 μM Compound: 1 (Rebeccamycin)	Cytotoxic concentration is tested against CEM-SS cells Cytotoxic concentration is tested against CEM-SS cells	[PMID: 9572888]
CEM-SS	IC₅₀	0.52 μM Compound: 1 (Rebeccamycin)	Anti-HIV-1 activity in CEM-SS cells was measured by the quantification of the reverse transcriptase activity, associated with the virus particles released from HIV-1 infected cells in the culture medium. Anti-HIV-1 activity in CEM-SS cells was measured by the quantification of the reverse transcriptase activity, associated with the virus particles released from HIV-1 infected cells in the culture medium.	[PMID: 10052965]
CEM-SS	IC₅₀	0.52 μM Compound: 1	Compound was tested for anti-HIV activity in HIV -I Lai infected CEM-SS cells. Compound was tested for anti-HIV activity in HIV -I Lai infected CEM-SS cells.	[PMID: 10346933]
CEM-SS	IC₅₀	0.52 μM Compound: 1 (Rebeccamycin)	Inhibitory concentration is tested in HIV-1 Lai-infected CEM-SS cells Inhibitory concentration is tested in HIV-1 Lai-infected CEM-SS cells	[PMID: 9572888]
HT-29	IC₅₀	0.3 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity in vitro against HT-29 (human colon carcinoma) cell line. Antiproliferative activity in vitro against HT-29 (human colon carcinoma) cell line.	[PMID: 11882002]
HT-29	IC₅₀	0.3 μM Compound: Rebeccamycin	In vitro antiproliferative activity against human colon carcinoma HT-29 cells In vitro antiproliferative activity against human colon carcinoma HT-29 cells	[PMID: 15743184]
K562	IC₅₀	0.2 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity in vitro against K-562 (human leukemia) cell line. Antiproliferative activity in vitro against K-562 (human leukemia) cell line.	[PMID: 11882002]
K562	IC₅₀	4 μM Compound: Reb	Anticancer activity against human K562 cells Anticancer activity against human K562 cells	[PMID: 18653350]
K562	IC₅₀	6 μM Compound: Rebeccamycin	Inhibitory concentration against K5662 leukemia cell line in MTS assay Inhibitory concentration against K5662 leukemia cell line in MTS assay	[PMID: 15801850]
L1210	IC₅₀	0.1 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity tested in vitro against L1210 (murine leukemia) cell line. Antiproliferative activity tested in vitro against L1210 (murine leukemia) cell line.	[PMID: 11882002]
L1210	IC₅₀	0.14 μM Compound: Rebeccamycin	Cytotoxicity activity against mouse L1210 cells by MTT assay Cytotoxicity activity against mouse L1210 cells by MTT assay	[PMID: 20566289]
L1210	IC₅₀	0.14 μM Compound: Rebeccamycin	In vitro antiproliferative activity against murine leukemia L1210 cells In vitro antiproliferative activity against murine leukemia L1210 cells	[PMID: 15743184]
P388	IC₅₀	0.3 μM Compound: 1 ; Rebeccamycin	Antiproliferative activity against P388 Murine Leukemia cells Antiproliferative activity against P388 Murine Leukemia cells	[PMID: 8893841]
P388	IC₅₀	0.5 μM Compound: 1	Inhibition of P388 murine leukemia cell proliferation Inhibition of P388 murine leukemia cell proliferation	[PMID: 9341921]
P388	IC₅₀	1.22 μM Compound: 1	In vitro inhibitory concentration against murine P388 leukemia cell proliferation In vitro inhibitory concentration against murine P388 leukemia cell proliferation	[PMID: 10346933]
P388	IC₅₀	1.22 μM Compound: 1 (Rebeccamycin)	Cytotoxicity against P388 leukemia cells Cytotoxicity against P388 leukemia cells	[PMID: 10052965]
P388	IC₅₀	1.22 μM Compound: 1 (Rebeccamycin)	Antiproliferative activity measured against P388 Leukemia cells Antiproliferative activity measured against P388 Leukemia cells	[PMID: 9572888]
P388	IC₅₀	10.5 μM Compound: 1 (Rebeccamycin)	Cytotoxicity against P388/CPT5 leukemia cells. Cytotoxicity against P388/CPT5 leukemia cells.	[PMID: 10052965]
P388CPT5	IC₅₀	10.5 μM Compound: 1	In vitro inhibitory concentration against murine P388CPT5 leukemia cell proliferation In vitro inhibitory concentration against murine P388CPT5 leukemia cell proliferation	[PMID: 10346933]
P388CPT5	IC₅₀	10.5 μM Compound: 1 (Rebeccamycin)	Antiproliferative activity measured against P388CPT5 cells resistant to Topoisomerase I inhibitor Camptothecin Antiproliferative activity measured against P388CPT5 cells resistant to Topoisomerase I inhibitor Camptothecin	[PMID: 9572888]
SW-620	IC₅₀	4 μM Compound: Reb	Anticancer activity against human SW620 cells Anticancer activity against human SW620 cells	[PMID: 18653350]
SW-620	IC₅₀	4 μM Compound: Rebeccamycin	Inhibitory concentration against SW620 colorectal carcinoma cell line in MTS assay Inhibitory concentration against SW620 colorectal carcinoma cell line in MTS assay	[PMID: 15801850]

体外実験

Rebeccamycin is an antitumor antibiotic produced by the actinomycete Saccharotrix aerocolonigenes with activity against several human tumor cell lines, including A549 (lung adenocarcinoma), HCT-116 (colon carcinoma), and KB (nasopharyngeal carcinoma) ^[1].
Rebeccamycin shows antibacterial activity against several Gram-positive bacteria, including Staphylococcus aureus and Streptococcus faecalis^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Rebeccamycin (2-256 mg/kg; i.p.; daily for 9 days) prolongs survival in B16 melanoma, L1210 leukemia^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

CDF1 mice (B16 melanoma, L1210 leukemia)^[2]
Dosage:

2, 4, 8, 16, 32, 64, 128, 256 mg/kg
Administration:

I.p.; daily for 9 days
Result:

Prolongation of survival of the mice at dose levels ranging from 8 to 256 mg/kg.

化学情報

CAS 番号 93908-02-2
分子量 570.38
分子式 C₂₇H₂₁Cl₂N₃O₇
SMILES

O=C(N1)C(C2=C3N([C@@H]([C@@H]([C@@H](O)[C@@H]4OC)O)O[C@@H]4CO)C5=C2C=CC=C5Cl)=C(C(C6=CC=C7)=C3NC6=C7Cl)C1=O
Structure Classification
- Antibiotics
- Other Antibiotics
Initial Source
- Microorganisms
the mycelium
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (278 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Merchant J, et al. Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats. Clin Cancer Res. 2002 Jul;8(7):2193-201. [Content Brief]

[2]. Bush JA, et al. Production and biological activity of rebeccamycin, a novel antitumor agent. J Antibiot (Tokyo). 1987 May;40(5):668-78. [Content Brief]

[3]. Sánchez C, et al. The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives. Chem Biol. 2002 Apr;9(4):519-31. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

Rebeccamycin

Topoisomerase アイソフォーム固有の製品をすべて表示

ADC Payloads アイソフォーム固有の製品をすべて表示

Antibiotic アイソフォーム固有の製品をすべて表示

生物活性

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

Rebeccamycin 関連分類

HY-19825 関連分類